Patents Assigned to OPSIDIO, LLC
  • Patent number: 12410246
    Abstract: The disclosure relates to antibodies and antigen-binding fragments thereof that bind to Stem Cell Factor (SCF). The antibodies and antigen-binding fragments thereof specifically bind to SCF248. The disclosure further relates to methods for making the antibodies, and to methods of use of the antibodies including methods of treatment for inflammatory and/or fibrotic diseases and disorders.
    Type: Grant
    Filed: November 2, 2023
    Date of Patent: September 9, 2025
    Assignee: Opsidio, LLC
    Inventor: Martin Phillips
  • Patent number: 11939373
    Abstract: The disclosure relates to antibodies and antigen-binding fragments thereof that bind to Stem Cell Factor (SCF). The antibodies and antigen-binding fragments thereof specifically bind to SCF248. The disclosure further relates to methods for making the antibodies, and to methods of use of the antibodies including methods of treatment for inflammatory and/or fibrotic diseases and disorders.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: March 26, 2024
    Assignee: OPSIDIO, LLC
    Inventor: Martin Phillips